JP2024506904A5 - - Google Patents
Info
- Publication number
- JP2024506904A5 JP2024506904A5 JP2023548654A JP2023548654A JP2024506904A5 JP 2024506904 A5 JP2024506904 A5 JP 2024506904A5 JP 2023548654 A JP2023548654 A JP 2023548654A JP 2023548654 A JP2023548654 A JP 2023548654A JP 2024506904 A5 JP2024506904 A5 JP 2024506904A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidine
- pyrrolidine
- carboxylic acid
- methylbenzofl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163148201P | 2021-02-11 | 2021-02-11 | |
| US63/148,201 | 2021-02-11 | ||
| PCT/US2022/016073 WO2022174012A1 (en) | 2021-02-11 | 2022-02-11 | INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506904A JP2024506904A (ja) | 2024-02-15 |
| JP2024506904A5 true JP2024506904A5 (cg-RX-API-DMAC7.html) | 2025-02-19 |
Family
ID=82837325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548654A Pending JP2024506904A (ja) | 2021-02-11 | 2022-02-11 | 治療剤としてのcGAS活性の阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240174684A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4291188A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024506904A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230144550A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116997339A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022218787A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3206520A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022174012A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112023020381A2 (pt) * | 2021-05-12 | 2023-11-21 | Boehringer Ingelheim Int | Derivados de piridina com substituintes cíclicos ligados por c como inibidores de cgas |
| CN117337292A (zh) | 2021-05-12 | 2024-01-02 | 勃林格殷格翰国际有限公司 | 作为cGAS抑制剂的具有N-连接环状取代基的吡啶衍生物 |
| WO2024035622A1 (en) * | 2022-08-10 | 2024-02-15 | Bellbrook Labs, Llc | INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS |
| CA3267076A1 (en) * | 2022-11-09 | 2024-05-16 | Boehringer Ingelheim International Gmbh | CYCLIC PYRIDINE DERIVATIVES USED AS CGAS INHIBITORS |
| CN121248633A (zh) * | 2022-11-09 | 2026-01-02 | 勃林格殷格翰国际有限公司 | 作为cGAS抑制剂的环状苯并咪唑衍生物 |
| WO2025233174A1 (en) | 2024-05-08 | 2025-11-13 | Boehringer Ingelheim International Gmbh | Benzimidazole derivatives as cgas inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2441958T3 (es) * | 2006-07-11 | 2014-02-07 | Janssen Pharmaceutica Nv | Moduladores de benzofuro- y benzotienopirimidina del receptor de histamina H4 |
| WO2008074445A1 (en) * | 2006-12-18 | 2008-06-26 | Ucb Pharma, S.A. | Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof |
| WO2013115167A1 (ja) * | 2012-01-31 | 2013-08-08 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | アムバチニブ誘導体 |
| US20200016136A1 (en) * | 2017-01-03 | 2020-01-16 | Viiv Healthcare Uk (No. 5) Limited | Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication |
| WO2020142729A1 (en) * | 2019-01-04 | 2020-07-09 | BellBrook Labs | Inhibitors of cgas activity as therapeutic agents |
-
2022
- 2022-02-11 CN CN202280019484.7A patent/CN116997339A/zh active Pending
- 2022-02-11 AU AU2022218787A patent/AU2022218787A1/en not_active Abandoned
- 2022-02-11 WO PCT/US2022/016073 patent/WO2022174012A1/en not_active Ceased
- 2022-02-11 CA CA3206520A patent/CA3206520A1/en active Pending
- 2022-02-11 EP EP22753392.4A patent/EP4291188A4/en active Pending
- 2022-02-11 KR KR1020237028625A patent/KR20230144550A/ko active Pending
- 2022-02-11 US US18/275,190 patent/US20240174684A1/en not_active Abandoned
- 2022-02-11 JP JP2023548654A patent/JP2024506904A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111315737B (zh) | 经砜吡啶烷基酰胺取代的杂芳基化合物 | |
| TWI583681B (zh) | 胺基嘧啶基化合物 | |
| CN104245671B (zh) | 含氮杂环化合物或其盐 | |
| CN109071546B (zh) | 作为jak抑制剂的吡唑并[1,5-a]吡嗪-4-基衍生物 | |
| CN107857755B (zh) | 作为trka激酶抑制剂的n-吡咯烷基、n′-吡唑基-脲、硫脲、胍和氰基胍化合物 | |
| CN104619698B (zh) | 吡咯烷衍生物及其作为补体途径调节剂的用途 | |
| CN115485026A (zh) | Nlrp3炎体途径抑制剂吡唑并[1,2-d][1,2,4]三嗪-2-基-乙酰胺 | |
| JP2022518148A5 (cg-RX-API-DMAC7.html) | ||
| JP2023523438A (ja) | 置換ヘテロ環式化合物 | |
| JP2017525757A5 (cg-RX-API-DMAC7.html) | ||
| IL305165A (en) | Tyk2 inhibitors and uses thereof | |
| EA033686B1 (ru) | Гетероциклические соединения, применимые в качестве модуляторов tnf-альфа | |
| TWI471322B (zh) | 新穎醯胺衍生物及其作為醫藥之用途 | |
| JP2017505794A5 (cg-RX-API-DMAC7.html) | ||
| JP2018512381A5 (cg-RX-API-DMAC7.html) | ||
| JP7260488B2 (ja) | ジヒドロピリミジン化合物、及び医薬におけるその使用 | |
| JP2007510668A (ja) | キノリノン化合物を合成する方法 | |
| JP2023509495A (ja) | RORγt阻害剤、その製造方法及び使用 | |
| TW201439066A (zh) | 含氮雜環化合物 | |
| TW201623239A (zh) | 新穎2-胺基-吡啶及2-胺基-嘧啶衍生物及其醫藥用途 | |
| CA3216503A1 (en) | Phosphorus derivatives as novel sos1 inhibitors | |
| JP2023542205A (ja) | 新規化合物 | |
| EP4265247A1 (en) | Compounds inducing production of proteins by immune cells | |
| AU2021323754A1 (en) | Benzylamine derivative, preparation method therefor and use thereof | |
| US20250283038A1 (en) | Compounds inducing production of proteins by immune cells |